Skip to main content

Advertisement

SpringerLink
Log in

Lebenslanges Impfen

Die Bedeutung von Impfungen im Lebensverlauf für eine alternde Bevölkerung

Lifelong vaccination

The importance of vaccinations for an aging population in the course of their lives

  • Schwerpunkt
  • Published:
Prävention und Gesundheitsförderung Aims and scope Submit manuscript

Zusammenfassung

Zur Bedeutung von Impfungen im Kindesalter als grundlegendes Element der Gesundheitsvorsorge herrscht weltweit Einigkeit. Zwischen Impfempfehlungen für ältere Menschen und tatsächlichen Impfraten besteht hingegen in Europa trotz der starken Evidenz für die Wirksamkeit der Immunisierung gegen Grippe, Pneumokokkenerkrankungen und andere impfpräventable Infektionskrankheiten eine Diskrepanz. Ältere Europäer sind gegen diese Krankheiten nicht genügend geimpft und somit nicht ausreichend geschützt. Strategien zur Überwindung von Impfbarrieren zu entwickeln, ist daher eine wichtige Zielsetzung für die europäische Gesundheitspolitik.

Das vorliegende Kurzdossier fasst weltweit gebräuchliche Methoden zur Förderung des Impfens zusammen und nennt Maßnahmen, die Entscheidungsträger ergreifen sollten, um die Impfraten zu verbessern und so ein gesundes Altern zu unterstützen. Die 4 Strategieziele sind: (1) Förderung von lebenslangen Impfprogrammen, um so die Krankheitslast durch impfpräventable Infektionskrankheiten zu senken und gesundes Altern zu fördern, (2) Verbesserung der Impfraten beim medizinischen Fachpersonal und Stärkung ihrer entscheidenden Rolle als Impfende, (3) Erweiterung der Impfangebote für Patienten, (4) verbesserte Aufklärung und Kenntnisse der Patienten.

Abstract

The importance of vaccinations during childhood as a basic element of health care is universally accepted. In contrast a discrepancy can be found in Europe between vaccination recommendations for older people and the actual vaccination rates despite strong evidence for the effectiveness of immunization against the flu, pneumococcal diseases, and other vaccine-preventable infectious diseases. Older Europeans are not sufficiently inoculated against these diseases and thus are not adequately protected. A crucial goal for European health care policy is thus to develop strategies to overcome barriers to vaccination.

This brief report summarizes the methods applied worldwide to promote vaccination and lists measures that decision makers should take to improve vaccination rates and thus support healthy aging. The four strategic goals are: (1) promotion of lifelong vaccination programs to lower the burden of disease due to vaccine-preventable infectious diseases and foster healthy aging; (2) improve vaccination rates among medical personnel and strengthen their decisive role as vaccination providers; (3) broaden the range of vaccinations offered to patients; and (4) improve information given to patients and their knowledge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Pocken, Diphtherie, Tetanus, Gelbfieber, Keuchhusten, Infektion durch Haemophilus influenzae Typ B, Poliomyelitis, Masern, Mumps, Röteln, Typhus und Tollwut.

Literatur

  1. Plotkin S, Plotkin S (2008) A Short History of Vaccination, Chapter 1 in Vaccines, 5th (edn) by In: Plotkin SA, Orenstein WA, Offit PA (eds). Elsevier Health Sciences

  2. Oxley H (2009) Policies for healthy ageing: An overview. OECD Health working papers. NO. 42. DELSA/HEA/WD/HWP1

  3. Madelin R (2008) Future challenges for EU health and customer policy. In: SANCO) D-GfHCD ed. Brussels: European commission

  4. Muller C, Gusmano MK (2005) Building a database for health policy. Issue brief. Alliance for Health & the Future 2(4)

  5. Suhrcke M, McKee M, Sauto AR et al (2005) The contribution of health to the economy in the European Union. Health & consumer protection directorate general. Luxembourg: Office for Official Publications of the European Communities. ISBN 92–894–9829–323

  6. Fingar AR, Francis BJ (1998) American College of Preventive Medicine Practice Policy Statement: adult immunizations. Am J Prev Med 14:156–158

    Article  CAS  PubMed  Google Scholar 

  7. Poland GA, Jacobson RM, Ovsyannikova IG (2009) Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine, doi:10.1016/j.vaccine.2009.01.069

  8. Bridges CB, Harper SA, Fukuda K et al (2003) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 52:1–34; quiz CE1–4

    Google Scholar 

  9. Nichol KL, D’Heilly SJ, Greenberg ME, Ehlinger E (2009) Burden of Influenza-Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years. CID 2009:48:292–298

    Google Scholar 

  10. Bonanni P, Boccalini S, Bechini A (2008) The expected impact of new vaccines and vaccination policies. J Public Health 16:253–259

    Article  Google Scholar 

  11. Fulop TG, Castle PS, Loeb M (2009) Immunosenescence and vaccination in nursing home residents. Aging Infect Dis 48:443–448

    Article  Google Scholar 

  12. Poland et al (2009)

  13. Madelin R (2008)

  14. Bovier PA, Chamot E, Bouvier GM, Loutan L (2001) Importance of patients‘ perceptions and general practitioners‘ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 19:4760–4767

    Article  CAS  PubMed  Google Scholar 

  15. Mieczkowski TA,Wilson SA (2002) Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine 20:1383–1392

    Article  PubMed  Google Scholar 

  16. Szucs TD, Muller D (2005) Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 23:5055–5063

    Article  PubMed  Google Scholar 

  17. Zimmerman RK, Santibanez TA, Fine MJ et al (2003) Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 21:1510–1517

    Article  PubMed  Google Scholar 

  18. Motbey C (2008) Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach. Hum Vaccin 4:341–343

    CAS  PubMed  Google Scholar 

  19. Schmitt HJ, Booy R, Aston R et al (2007) How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 5:11

    Article  PubMed  Google Scholar 

  20. Johnson DR, Nichol KL, Lipczynski K (2008) Barriers to adult immunization. Am J Med 121:28–35

    Article  Google Scholar 

  21. Schmitt HJ, Booy R, Aston R et al (2007) How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 5:11

    Article  PubMed  Google Scholar 

  22. Motbey C (2008) Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach. Hum Vaccin 4:341–343

    CAS  PubMed  Google Scholar 

  23. Zebrack JR, Brown KW (2008) Preventive health for women: screening and immunizations. Med Clin North Am 92:1011–1035, ix

    Article  PubMed  Google Scholar 

  24. Berg GD et al (2004) Reducing medical service utilization by encouraging vaccines: Randomised controlled trial. Am J Prev Med 27(4):284–288

    PubMed  Google Scholar 

  25. Schmitt HJ, Booy R, Aston R et al (2007) How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 5:11

    Article  PubMed  Google Scholar 

  26. Motbey C (2008) Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach. Hum Vaccin 4:341–343

    CAS  PubMed  Google Scholar 

  27. Fedson DS (1987) Influenza prevention and control. Past practices and future prospects. Am J Med 82:42–47

    Article  CAS  PubMed  Google Scholar 

  28. Fedson DS, Houck P, Bratzler D (2000) Hospital-based influenza and pneumococcal vaccination: Sutton’s Law applied to prevention. Infect Control Hosp Epidemiol 21:692–699

    Article  CAS  PubMed  Google Scholar 

  29. Sokos DR, Skledar SJ, Ervin KA et al (2007) Designing and implementing a hospital-based vaccine standing orders programme. Am J Health Syst Pharm 64:1096–1102

    Article  PubMed  Google Scholar 

  30. Johnson DR, Nichol KL, Lipczynski K (2008) Barriers to adult immunization. Am J Med 121:28–35

    Article  Google Scholar 

  31. Szucs TD, Muller D (2005) Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 23:5055–5063

    Article  PubMed  Google Scholar 

  32. Wendelboe AM, Njamkepo E, Bourillon A et al (2007) Transmission of Bordetella pertussis to Young Infants. Pediatr Infect Dis J 26(4):293–299

    Article  PubMed  Google Scholar 

  33. Berg GD, Thomas E, Silverstein S et al (2004) Reducing medical service utilization by encouraging vaccines: randomized controlled trial. Am J Prev Med 27:284–288

    PubMed  Google Scholar 

  34. Gazmararian JA, Williams MV, Peel J, Baker DW (2003) Health literacy and knowledge of chronic disease. Patient Educ Couns 51:267–75

    Article  PubMed  Google Scholar 

  35. Jacobson TA, Thomas DM, Morton FJ et al (1999) Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial. JAMA 282:646–650

    Article  CAS  PubMed  Google Scholar 

  36. Bloom H (2007) Immunizations: Not just for kids. In: International Longevity Center – USA. http://www.ilcusa.org/pages/publications/ageism- sleep/immunizations–not-just-for-kids.php ed. International Longevity Center – USA, NewYork, pp 1–8

Download references

Author information

Authors and Affiliations

  1. Downstate Medical Center, State University of New York, New York, USA

    M.K. Gusmano

  2. Abteilung für Geriatrie, Universitätsklinik Genf, Genf, Schweiz

    J.-P. Michel

Authors
  1. M.K. Gusmano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.-P. Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

Anhang

Anhang

Tab. 1 Tabellarischer Überblick
Full size table

Die „Alliance for Health & the Future“ unter dem Dach des ILC-USA dankt Sanofi Pasteur MSD für die großzügige Unterstützung der hier vorgestellten Arbeit durch einen freien Forschungszuschuss. Für den Inhalt dieses Kurzdossiers ist ausschließlich die Alliance for Health & the Future verantwortlich.

Michael K. Gusmano (Ph. D.) ist Assistant Professor of Health Policy und Management an der State University of New York, Downstate Medical Center, und Co-Director des World Cities Project am International Longevity Center – USA.

Prof. Dr. Jean-Pierre Michel ist Leiter der Abteilung für Geriatrie an der Universitätsklinik Genf und Academic Director der European Union Geriatric Medicine Society.

Der wissenschaftliche Beratungsausschuss für das Impfprojekt

Tamsin Rose – Vorsitzende Geschäftsführerin von Tamarack Ltd.

Prof. Jean-Pierre Baeyens – Präsident der IAGG, Region Europa

Dr. Rudolph Fitzner – Bundesarbeitsgemeinschaft der Senioren-Organisationen Deutschland (BAGSO)

Dr. Paul Kowal – Weltgesundheitsorganisation

Dr. Stephania Maggi – Center on Aging, National Research Council

Dr. Antonyia Parvanova – Mitglied der Nationalversammlung der Republik Bulgarien

Prof. Ian Philp – Sheffield Institute for Studies on Ageing

Dr. Jean-Marie Robine – Universität Montpellier

Korrespondierender Autor

Dr. R. Fitzner

Vorstandsmitglied der Bundesarbeitsgemeinschaft der Seniorenorganisationen e. V., Bonngasse 10, 53111 Bonn, E-Mail: rudolf.fitzner@charite.de.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gusmano, M., Michel, JP. Lebenslanges Impfen. Praev Gesundheitsf 5 (Suppl 1), 16–22 (2010). https://doi.org/10.1007/s11553-010-0241-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11553-010-0241-6

Schlüsselwörter

Keywords

Search

Navigation